Exchange Traded Concepts, LLC Eli Lilly & CO Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 34,077 shares of LLY stock, worth $25.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

34,077

Previous 31,296 8.89%

Holding current value

$25.4 Million

Previous $28.3 Million 6.55%

% of portfolio

0.72%

Previous 0.73%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $2.15 Million - $2.67 Million	2,781 Added 8.89%	34,077 $30.2 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $21.2 Million - $26.6 Million	29,315 Added 1479.81%	31,296 $28.3 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $24.3 Million - $32.6 Million	-41,115 Reduced 95.4%	1,981 $1.54 Million
Q4 2023 Jan 05, 2024	BUY	$525.19 - $619.13 $1.5 Million - $1.77 Million	2,851 Added 7.08%	43,096 $25.1 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $4.15 Million - $5.72 Million	-9,540 Reduced 19.16%	40,245 $21.6 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $6.28 Million - $8.4 Million	-17,918 Reduced 26.47%	49,785 $23.3 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $9.65 Million - $11.3 Million	31,058 Added 84.75%	67,703 $23.3 Million
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $817,701 - $952,785	-2,543 Reduced 6.49%	36,645 $13.4 Million
Q3 2022 Oct 07, 2022	SELL	$296.48 - $337.87 $172,847 - $196,978	-583 Reduced 1.47%	39,188 $12.7 Million
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $11 Million - $12.9 Million	39,566 Added 19300.49%	39,771 $12.9 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $15.6 Million - $19.4 Million	-66,369 Reduced 99.69%	205 $59,000
Q4 2021 Jan 13, 2022	BUY	$224.85 - $279.04 $166,164 - $206,210	739 Added 1.12%	66,574 $18.4 Million
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $2.59 Million - $3.19 Million	11,684 Added 21.58%	65,835 $15.2 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $1.37 Million - $1.78 Million	7,609 Added 16.35%	54,151 $12.4 Million
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $2.7 Million - $3.5 Million	-16,441 Reduced 26.1%	46,542 $8.7 Million
Q4 2020 Jan 19, 2021	SELL	$130.46 - $172.63 $1.1 Million - $1.46 Million	-8,467 Reduced 11.85%	62,983 $10.6 Million
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $611,930 - $707,809	4,185 Added 6.22%	71,450 $10.6 Million
Q2 2020 Jul 15, 2020	BUY	$136.42 - $164.18 $8.72 Million - $10.5 Million	63,951 Added 1929.72%	67,265 $11 Million
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $1,785 - $2,210	15 Added 0.45%	3,314 $460,000
Q4 2019 Jan 22, 2020	BUY	$106.92 - $132.43 $352,729 - $436,886	3,299 New	3,299 $434,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Eli Lilly & CO Transaction History